Live Breaking News & Updates on Last Subject

Stay updated with breaking news from Last subject. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AIM ImmunoTech Completes Treatment of Last Subject in Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions

AIM ImmunoTech Completes Treatment of Last Subject in Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Jenene Thomas , Thomask Equels , Immunotech Inc , Company Phase , Tech Completes Treatment , Last Subject , Evaluating Ampligen , Executive Officer Thomas , Fatigue Score , Six Minute Walk Test , Cognitive Function Score , Sleep Disturbance , Private Securities Litigation Reform Act ,